Available in English and Spanish, this e-newsletter separates fact from fiction on over 40 heart topics by Texas Heart Medical Group's Dr. Stephanie Coulter.
Texas Heart Institute (THI) conducts research through clinical trials as part of our mission to improve heart health. The trials conducted at THI are designed to test the safety and effectiveness of innovative new treatments and medications for patients.
Innovative Technologies & Techniques is produced at THI and explores promising advances in medicine that aim to extend the life of cardiac patients and patients at risk for series heart and vascular conditions. In response to the evolving pandemic, emerging topics related to COVID-19 are featured in the special Cardiology in the Time of COVID-19 episodes.
Our progress would not be possible without our donor community. Help support our mission by giving today.
The goal of the annual awareness day on February 22 is to increase recognition of the specific risks and symptoms of heart valve disease, improve detection and treatment, and ultimately save lives. While heart valve disease can be can be disabling and deadly, available treatments can save lives, making education and awareness particularly important. On this day and throughout the year, the campaign partners—50+ non-profits, advocacy organizations, professional societies, and hospitals and heart centers—are helping to spread the word about valve disease.